Clinical Trial Update: Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 [Phase 3]

View source ↗

Summary

This update notes an additional six-month safety follow-up after completion of precursor study 880801 in a Phase 3 trial for prophylaxis of Ross River Virus inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ross River Virus Infection

Snippet

Sponsor: Alachua Government Services, Inc. | Conditions: Prophylaxis of Ross River Virus Infection | Phase 3 | Status: COMPLETED